RISS Versus SPSIP Block in Modified Radical Mastectomy
Recruiting · NCT07659990 · Interventional (participants receive a specific treatment)
View the official record on ClinicalTrials.gov →Interventions studied
Rhomboid Intercostal-Subserratus Plane BlockSerratus Posterior Superior Intercostal Plane Block
What this trial is about
This prospective randomized double-blind controlled trial aims to compare the postoperative analgesic efficacy and dermatomal spread of rhomboid intercostal-subserratus plane (RISS) block and serratus posterior superior intercostal plane (SPSIP) block in patients undergoing modified radical mastectomy. Postoperative pain scores, opioid consumption, rescue analgesic requirements, block-related complications, and quality of recovery outcomes will be evaluated.
Who can take part
Age range
18 Years to 75 Years
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Female patients aged 18-75 years
- ASA physical status I-III
- Scheduled for elective unilateral modified radical mastectomy with axillary dissection under general anesthesia
- Provision of written informed consent
Exclusion criteria
- Anticoagulant therapy
- Bleeding diathesis
- Known allergy to local anesthetics or opioids
- Infection at the block application site or previous surgery in the block area
- Cognitive impairment preventing NRS assessment
- Pregnancy or lactation
- Chronic opioid use
- Severe hepatic or renal failure
- Refusal to participate in the study
- Technical inability to perform the block or failed block
Where it is running
1 location listed.
- Bursa City Hospital - Bursa, Nilüfer, Turkey (Türkiye)